PHARMACEUTICAL IP

  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Events & Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Events & Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our offering
  • Fractional in-house
  • Sectors
  • Evolve Insights
  • Our team
  • Join us
  • Our offering
  • Fractional in-house
  • Sectors
  • Evolve Insights
  • Our team
  • Join us

The future of the patent profession: Are we looking into an AI abyss?

  • Sector: Patent law
  • 8th May 2026
AI presents a huge dilemma for patent attorneys. There is no doubt that AI will have a dramatic impact on the profession and the business model that many firms have relied on for decades.
 

Originally posted on IPKat.

Faced with this challenge, there is a growing divide in the profession between the firms and attorneys who are actively adopting AI, and those that remain stubbornly AI-sceptic. Amongst the AI adopters, there is also a huge diversity in marketing approach. Whilst some firms are choosing not to mention their use of AI at all on their websites, others are actively marketing AI-based discounts. Where does all this leave the profession? 

Heads in the sand

Many patent attorneys remain highly AI-sceptic. Indeed, many attorneys openly admit to using no AI at all in their professional work. This admission is usually followed with an anecdote about an AI they used a year ago that made a hilariously-incorrect hallucinatory error, or a story about some terrible AI-drafted claims. 

The hesitation felt by many in the profession is logical if you consider that much of the patent profession relies heavily on the drafting and prosecution billable hour. If a firm adopts an AI tool that significantly reduces the time required to, for example, draft a prosecution response, it faces a direct threat to its revenue stream. If the volume of work remains static and is dictated by the frequency of EPO office actions, then speeding up the process simply erodes revenue.  It is therefore no surprise that large firms focused on high volume drafting and prosecution seem less than enthused by AI. 

However, simply ignoring AI is unlikely to be sustainable. With AI capabilities ever increasing, cost-conscious clients are increasingly likely to demand at least some AI-assisted efficiency that translates into reduced fees. 

The race to the bottom

In contrast to the AI-naysayers and sceptics, some firms are actively marketing cheaper services based on substantial AI-assisted reductions in patent prosecution costs. This is not just start-ups and AI-native law companies, but Tier 1 firms. Beyond the high-level marketing-spiel, it remains unclear how such reductions (up to 30% in some cases) are calculated. If the same level of quality is promised from the AI-assisted service, this approach would also seem to be kickstarting a race to the bottom. There may also come a point where clients may simply ask why they are paying their attorney to ask ChatGPT to draft and prosecute their patent, when they could simply do this for themselves.

There is a mode of thought that AI will kill the billable hour, replacing it with a fixed-fee model. However, shifting to fixed fees does not solve the problem, given that it may still be difficult to convince clients that they should be paying high fees when the attorney is using off-the-shelf AI tools to complete the same work as before in a fraction of the time. The firms refusing to adopt AI may then find themselves out-competed by those who are. 

AI for AI’s sake

In the middle, are all the firms that have rolled out AI tools firm-wide but without a clear external narrative, with their websites often remaining silent on the use of AI or providing only vague references. It seems that firms are struggling to define exactly what problem they are solving for their clients or their business. The internal AI-task-force of attorneys tasked with trialling off-the-shelf tools for the firm appears to be almost a universal.

However, firms simply seeking to adopt an off-the-shelf AI-wrapper (simply because they feel they have to) are putting themselves at the mercy of a highly fluid and precarious legal tech market (Evolve insights). These firms are at risk of becoming overly reliant on specific service providers whose products may quickly become obsolete. We have already seen this pattern in the software industry where specialized AI coding solutions, such as Devin AI, were rapidly superseded by the native capabilities of LLMs like Claude Code, despite huge initial investment and venture capital excitement. As the Vice President of Google’s Global Start-up Organization Darren Mowry put it, “if you’re really just counting on the back-end model to do all the work and you’re almost white-labelling that model, the industry doesn’t have a lot of patience for that anymore”. As AI models improve the functionality gap that wrappers once filled is closed by the model providers themselves at dramatically reduced costs. We are already seeing this in the legal tech world with the recent release of Claude Legal.

Patent firms that invested heavily in complex legal tech platforms twelve months ago may find themselves tethered to expensive and unnecessary AI wrappers that might not survive the next two years. Firms must therefore make a conscious choice about the value proposition of their chosen tools rather than simply adopting technology because they feel they must.

Analysis

Learning how to use AI is one thing, understanding why you should use AI is another. Whilst there is certainly currently a lot of AI hype, it is also certain that AI will change the patent profession. We are an industry based on the digestion, interpretation and production of the written word, all tasks that AI excels at. The pace of change is also astounding. The profession is inevitably going to look very different in 10 years’ time from what it does today. Patent attorneys are therefore going to need to figure out not only how to use AI, but why they should use it.

Author: Rose Hughes

Rose is a biotech and pharmaceutical patent specialist with over a decade of experience in intellectual property. Rose is a patent attorney at Evolve, where she leverages our unique fractional in-house model to provide clients with deep patent law expertise combined with the strategic commercial oversight typically associated with senior in-house counsel.

With a PhD in Immunology from UCL, Rose applies her technical background to complex innovations in biologics, cell and gene therapies, and the rapidly emerging field of AI-assisted drug development. Previously, Rose held the role of Director. Patents at AstraZeneca, where she was responsible for global IP portfolios and IP strategy at every stage of the pharmaceutical pipeline, from platform development and on-market commercialization to SPCs and patent term extensions.

A recognized thought leader in the field, Rose has been a regular contributor to IPKat since 2018, offering practical insights into European patent law developments. She is also a frequent speaker on the epi podcast, a guest lecturer for the Brunel University IP law Postgrad Certificate, and a contributing author to published books A User’s Guide to Intellectual Property in Life Sciences (2021) and Developments and Directions in Intellectual Property Law (2023).

Related insights...

Is AI software for IP just expensive wrapping paper?

  • 14th May 2026
At the last count, there were more than seventy companies offering AI-assisted IP software solutions. Most of these companies are less than two years old.

Are AI-generated materials legally privileged? United States v. Heppner

  • 13th May 2026
Legal privilege ensures that you can share sensitive information with your lawyers without fear of it being used against you in court. This protection is critical in all fields of law. In patent law, without the assurance of secrecy, the ability of a patentee or a defendant to receive candid advice would be severely diminished.…

Use of AI in the patent industry: Are you behind the wheel or waiting for the bus?

  • 1st May 2026
It took a global pandemic to move some patent firms away from paper files. Today, it seems that patent attorneys are finally entering modernity with the growing adoption in the industry of automation tools for patent drafting and prosecution case management. Interestingly, much of this is being sold and promoted as “AI”, despite much of…

Use of AI in the patent industry: The spectre of hallucination

  • 10th October 2025
What are the risks of AI hallucinations for the patent industry?

Use of AI in the patent industry: Solving the confidentiality problem

  • 10th October 2025
How can patent attorneys ensure client confidentiality when using AI software for patents.

Evolve AI: Building AI tools for IP that are expert-led and pharma-specific

  • 2nd October 2025
We believe that the value of AI for our profession lies in developing highly specialised tools that build upon and incorporate domain-specific attorney expertise.

Is it time for patent offices to enter the bioinformatic age?

  • 13th June 2025
In a world in which incalculable amounts of sophisticated sequence data is freely available, are the clunky processes necessary to input patent sequence data really fit-for-purpose?

An LLM is not (yet) a person skilled in the art (T 1193/23)

  • 20th May 2025
The EPO clarifies that an LLM interpretation of a technical term in a patent is not yet evidence of how a skilled person would interpret the term.

OpenAI’s large language model (LLM) patents

  • 29th April 2025
For tech innovators seeking to understand evolving intellectual property strategies, OpenAI’s recent pivot offers essential guidance: far from relying solely on trade secrets, the AI leader is now aggressively pursuing and accelerating patent grants, signaling a significant shift.

“Using AI tools to help assess inventive step”: A response to the CIPA journal article

  • 16th July 2024
This post is based on a previous article on IPKat. The cover article of the May 2024 edition of the CIPA Journal proposed a new test for inventive step using AI. The article was inspired by the EPO’s AI assisted search tool, AI-PreSearch. The CIPA journal article proposes to use an AI derived measurement of semantic similarity between the…
All Insights

evolve® is a trading entity of Evolve Intellectual Property Limited. Evolve Intellectual Property Limited is regulated by the Intellectual Property Regulation Board (IPReg). Details of the UK professional rules can be found on the IPReg website

registered address: 49 Greek Street, London, England, W1D 4EG

website out of house

© 2026 All Rights Reserved

Keep in touch

Subscribe

Contact Us